Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Anaes TopicsAnaesthetic adjuncts

Anaes · Anaesthetic adjuncts

Methadone

Also known as Methadone hydrochloride · Long-acting mu agonist with NMDA antagonism

Methadone for the anaesthesia fellowship exams: a synthetic mu agonist with NMDA antagonism, a long and variable half-life that outlasts its analgesic action, QT prolongation, cytochrome P450 interactions, non-linear opioid conversion, and the single intraoperative dose.

high8 referencesUpdated 23 Oct 20265 min readSource-verified · Oct 2026

Checked against its sources on 23 Oct 2026

Practise this topic

  • 16 MCQs

Your progress

Saved on this device.

Practise this topic16 MCQs with explanations

Target exams

ANZCAFRCAABAEDAICFCAIFCA_SA

Red flags

  • The analgesic action of methadone lasts 4 to 8 hours but its plasma elimination half-life is 8 to 59 hours; its peak respiratory depressant effects occur later and persist longer than its peak analgesic effects.
  • QT prolongation and torsades de pointes have occurred during methadone treatment, more commonly at doses above 200 mg/day.
  • The potency of methadone relative to other opioids is non-linear and increases with increasing dose; deaths have occurred in opioid-tolerant patients during conversion.
  • Methadone is a long-acting depressant (36 to 48 hours), whereas opioid reversal agents act for one to three hours: monitor until spontaneous respiration is reliably re-established.
On this page
Study tools

Your progress

Saved on this device.

Practise this topic16 MCQs with explanations

Target exams

ANZCAFRCAABAEDAICFCAIFCA_SA

Red flags

  • The analgesic action of methadone lasts 4 to 8 hours but its plasma elimination half-life is 8 to 59 hours; its peak respiratory depressant effects occur later and persist longer than its peak analgesic effects.
  • QT prolongation and torsades de pointes have occurred during methadone treatment, more commonly at doses above 200 mg/day.
  • The potency of methadone relative to other opioids is non-linear and increases with increasing dose; deaths have occurred in opioid-tolerant patients during conversion.
  • Methadone is a long-acting depressant (36 to 48 hours), whereas opioid reversal agents act for one to three hours: monitor until spontaneous respiration is reliably re-established.
The one-line answer

Methadone is a synthetic mu agonist with actions qualitatively similar to morphine, and some data indicate it is also an NMDA receptor antagonist.[6] Its analgesic action lasts 4 to 8 hours but its plasma elimination half-life is 8 to 59 hours, its potency relative to other opioids is non-linear, and it can prolong the QT interval.[6]

Mechanism of action

Methadone hydrochloride is a mu agonist, a synthetic opioid analgesic with multiple actions qualitatively similar to those of morphine. Some data also indicate that methadone acts as an antagonist at the NMDA receptor; the contribution of NMDA antagonism to its efficacy is unknown.[6]

Methadone has a unique mechanism of action compared with all other opioids, and for this reason holds a niche role in the management of opioid-induced hyperalgesia and central sensitisation.[1]

Methadone produces respiratory depression by direct action on brain stem respiratory centres, reducing their responsiveness to increases in carbon dioxide tension and to electrical stimulation.[6]

Anaesthesia Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Anaesthesia fellowship library.

Sign in to continueSee pricing
References8ShowHide
  1. [1]Kreutzwiser D, Tawfic QA Methadone for Pain Management: A Pharmacotherapeutic Review CNS Drugs, 2020.PMID 32564328
  2. [2]Murphy GS, Szokol JW, Avram MJ, et al. Intraoperative Methadone for the Prevention of Postoperative Pain: A Randomized, Double-blinded Clinical Trial in Cardiac Surgical Patients Anesthesiology, 2015.PMID 25837528
  3. [3]Murphy GS, Avram MJ, Greenberg SB, et al. Postoperative Pain and Analgesic Requirements in the First Year after Intraoperative Methadone for Complex Spine and Cardiac Surgery Anesthesiology, 2020.PMID 31939849
  4. [4]El Sherbini A, Liblik K, Lee J, et al. Opioids-induced inhibition of HERG ion channels and sudden cardiac death, a systematic review of current literature Trends Cardiovasc Med, 2024.PMID 37015297
  5. [5]Mercadante S, Caraceni A Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review Palliat Med, 2011.PMID 21708857
  6. [6]Mylan Institutional LLC METHADONE HYDROCHLORIDE injection, solution — prescribing information. DailyMed, 2026.Source
  7. [7]VistaPharm, LLC METHADONE HYDROCHLORIDE tablet — prescribing information. DailyMed, 2026.Source
  8. [8]Nunez-Rodriguez E, et al. Evaluating respiratory depression after methadone administration in surgical patients: protocol for a systematic review and meta-analysis BMJ Open, 2025.PMID 40447426

Test yourself

Practise what you just read

  • 16 MCQs
Anaesthesia Pro

$29/ monthor $279 / year

The complete Anaesthesia library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousMetaraminol — the mixed-acting vasopressor (alpha-1 plus indirect noradrenaline release)Anaesthetic adjunctsNextMorphineAnaesthetic adjuncts